| News Updates |
 |
What's happening with the anti-HIV program PEPFAR? It depends whom you ask
NPR | February 13, 2025
|
|
US spells out life-saving HIV treatment that can continue during aid pause
Reuters | February 1, 2025
|
|
What to Do if You Can’t Get Your HIV Medication Costs Covered
The Body | January 29, 2025
|
|
Combination of Dolutegravir, Lamivudine Effective in People Living With HIV
American Journal of Managed Care | January 22, 2025
|
|
NIAID Study Describes Successful Treatment Regimen for Person with Multidrug-Resistant HIV
NIH | January 16, 2025
|
|
DoxyPEP Tied to Decreases in Sexually Transmitted Infections
Health Day | January 7, 2025
|
|
WHO to Develop Lenacapavir and HIV Testing Guidelines
Managed Healthcare | January 7, 2025
|
|
Twice-Yearly Lenacapavir Could Support HIV Prevention in Vulnerable Populations
JAMA | January 3, 2025
|
|
Anticipated facilitators and barriers for long-acting injectable antiretrovirals as HIV treatment and prevention in Vietnam: a qualitative study among...
BMC Infectious Diseases - BioMed Central | December 25, 2024
|
|
Doravirine/Islatravir HIV Treatment Combo Looks Good in Late-Stage Trials
POZ Magazine | December 25, 2024
|
|
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Twice-Yearly Lenacapavir for HIV Prevention
Gilead | December 19, 2024
|
|
Gilead plans to halt free access to an HIV drug, worrying patient advocates
STAT | December 19, 2024
|
|
Global leaders in the HIV response call for access to long-acting medicines
UNAIDS | December 10, 2024
|
|
Weight Gain While Treating HIV: Why It Happens
WebMD | November 14, 2024
|
|
Code Pharma’s Gammora® Demonstrates Highly Favorable Outcomes Toward a Potential Cure for HIV
BusinessWire | November 12, 2024
|
|
Gilead and Merck Report Successful Phase 2 Results for Investigational Once-Weekly HIV Treatment
Contagion Live | November 11, 2024
|
|
Curr Opin HIV AIDS | 2024 Nov 5
|
|
Shaping the Next Era of HIV Therapeutics and Care
POZ Magazine | October 30, 2024
|
|
FDA Approves New UTI Antibiotic
Conexiant | October, 25, 2024
|
|
Updated Coverage Guidance Under the Affordable Care Act: Long-Acting PrEP
HIV.gov | October 24, 2024
|
|
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir...
BioSpace | October 21, 2024
|
|
Biden Sides with Insurers, Shifting More Costs to Patients
ADAP | October 17, 2024
|
|
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
ViiV Healthcare | October 7, 2024
|
|
Biopharma firm Gilead announces lenacapavir licensing for HIV treatment
The Indian Express | October 4, 2024
|
|
Gilead Signs Voluntary Licensing Agreements for Lenacapavir PrEP
POZ | October 4, 2024
|
|
HIV prevention: why a new injectable drug could be such a breakthrough
The Conversation | October 3, 2024
|
|
A Promising Injectable for HIV Prevention
Yale School of Medicine | October 3, 2024
|
|
Fact Sheet: Medicare Part B Coverage of Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) Prevention
CMS.gov | September 30, 2024
|
|
Virologic suppression rate and associated factors for third-line HIV treatment in Addis Ababa, Ethiopia
BMC Infectious Diseases - BioMed Central | September 28, 2024
|
|
Long-acting injectable lenacapavir continues to show promising results for HIV prevention
World Health Organization (WHO) | September 26, 2024
|
|
Drug-Related Problems in HIV Treatment Failure
Cureus | September 21, 2024
|
|
New two-dose HIV vaccine strategy shows promise for stronger immune response
News Medical | September 20, 2024
|
|
Medicaid must prepare to cover twice-yearly HIV prevention injection
STAT | September 19, 2024
|
|
This preventive drug could be a 'game changer' in ending the HIV epidemic
NPR | September 17, 2024
|
|
Type 2 Diabetes Drug Metformin May Help Reduce Viral Reservoir in People with HIV
Healthline | September 16, 2024
|
|
The Significance of Antimicrobial Stewardship in Dentistry
Contagion Live | September 9, 2024
|
|
HIV antiretroviral therapy saves over a million lives each year
Our World in Data | September 2024
|
|
Investors can play 'pivotal role' in addressing antimicrobial resistance, report says
CIDRAP | August 30, 2024
|
|
Breakthrough HIV drug Lenacapavir Shows promising results in recent study
FOX5 | August 16, 2024
|
|
Reproductive-Aged Women With HIV Express Interest in Long-Acting ART Options
IDA | August 15, 2024
|
|
Sussex launches new online HIV medication service
BBC | August 11, 2024
|
|
Dovato (dolutegravir/lamivudine) - Uses, Side Effects, and More
WebMD | August 11, 2024
|
|
Doctor behind trial of HIV prevention drug recounts breakthrough moment
The Guardian | July 26, 2024
|
|
With PrEP Effort Lagging, Positive Results for Twice-Yearly Lenacapavir May Give a Lift
Managed Healthcare | July 25, 2024
|
|
Experts say a twice-yearly injection that offers 100% protection against HIV is ‘stunning’
AP | July 24, 2024
|
|
What is an Investigational HIV Drug?
NIH | July 23, 2024
|
|
HIV drug could be made for just $40 a year for every patient
The Guardian | July 23, 2024
|
|
CDC Releases Antimicrobial Resistant Threats Data From During 2021-2022
CDC | July 16, 2024
|
|
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1
AACP Journals | July 15, 2024
|
|
ViiV Healthcare To Announce Data From Largest Head-To-Head Randomised Clinical Trial For 2-Drug Regimen Dovato Against 3-Drug...
ViiV Healthcare | July 15, 2024
|
|
Biden administration appeals jury finding in battle over patents for HIV prevention pills
STAT | July 8, 2024
|
|
Presentation: Implementation of Long-Acting Drugs for the Treatment and Prevention of HIV
IAS | July 23, 2034
|
|
A new way to prevent HIV delivers dramatic results in trial: PURPOSE 1
KRWG | July 3, 2024
|
| |
|
